» Articles » PMID: 32742319

STIM1 Controls Calcineurin/Akt/mTOR/NFATC2-mediated Osteoclastogenesis Induced by RANKL/M-CSF

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2020 Aug 4
PMID 32742319
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Store-operated Ca entry (SOCE) is the stable calcium channel influx in most cells. It consists of the cytoplasmic ion channel ORAI and endoplasmic reticulum receptor stromal interaction molecule 1 (STIM1). Abolition of SOCE function due to ORAI1 and STIM1 gene defects may cause non-perspiration, ectoderm dysplasia and skeletal malformations with severe combined immunodeficiency (CID). Calcineurin/mammalian target of rapamycin (mTOR)/nuclear factor of activated T cells 2 (NFATC2) is an important signalling cascade for osteoclast development. Calcineurin is activated by Ca via SOCE during osteoclastogenesis, which is induced by receptor activator of NF-κB ligand (RANKL) and macrophage colony-stimulating factor (M-CSF). However, the underlying mechanism has remained to be fully elucidated, which was therefore the aim of the present study. In the current study, flow cytometry was used to examine the effect of a number of STIM1 mutations on proliferation, differentiation, and expression of osteolysis-associated proteins in Bone marrow-derived mononuclear macrophages (BMDM). The calcineurin/AKT/mTOR/NFATC2 signaling cascade activation were also assessed. BMDMs were obtained from three patients with STIM1 mutations (p.E136X, p.R429C and p.R304W). These mutations, which exhibited abolished (p.E136X, p.R429C) or constitutively activated (p.R304W) SOCE, failed to respond to RANKL/M-CSF-mediated induction of normal osteoclastogenesis. In addition, activation of the calcineurin/Akt/mTOR/NFATC2 signalling cascade induced by RANKL/M-CSF was abnormal in the BMDMs with STIM1 mutants compared with that in BMDMs from healthy subjects. In addition, overexpression of wild-type STIM1 restored SOCE in p.R429C- and p.E136X-mutant BMDMs, but not in p.R304W-mutant BMDMs. Of note, calcineurin, cyclosporin A, mTOR inhibitor rapamycin and NFATC2-specific small interfering RNA restored the function of SOCE in p.R304W-mutant BMDMs. The present study suggests a role for SOCE in calcineurin/Akt/mTOR/NFATC2-mediated osteoclast proliferation, differentiation and function.

Citing Articles

Single-cell RNA landscape of osteoimmune microenvironment in osteoporotic vertebral compression fracture and Kümmell's disease.

Xu Y, Huang S, Li Z, Dai L, Wu H, Wang P Front Cell Dev Biol. 2024; 11:1276098.

PMID: 38161331 PMC: 10755405. DOI: 10.3389/fcell.2023.1276098.


A Genome-Wide Association Study of the Chest Circumference Trait in Xinjiang Donkeys Based on Whole-Genome Sequencing Technology.

Liu L, Chen B, Chen S, Liu W Genes (Basel). 2023; 14(5).

PMID: 37239441 PMC: 10217852. DOI: 10.3390/genes14051081.


Too much of a good thing: The case of SOCE in cellular apoptosis.

Benson J, Trebak M Cell Calcium. 2023; 111:102716.

PMID: 36931194 PMC: 10481469. DOI: 10.1016/j.ceca.2023.102716.


Role of K and Ca-Permeable Channels in Osteoblast Functions.

Kito H, Ohya S Int J Mol Sci. 2021; 22(19).

PMID: 34638799 PMC: 8509041. DOI: 10.3390/ijms221910459.


Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target.

Seligson N, Maradiaga R, Stets C, Katzenstein H, Millis S, Rogers A NPJ Precis Oncol. 2021; 5(1):43.

PMID: 34021224 PMC: 8140100. DOI: 10.1038/s41698-021-00177-0.


References
1.
Hogan P, Chen L, Nardone J, Rao A . Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 2003; 17(18):2205-32. DOI: 10.1101/gad.1102703. View

2.
Boyle W, Simonet W, Lacey D . Osteoclast differentiation and activation. Nature. 2003; 423(6937):337-42. DOI: 10.1038/nature01658. View

3.
Parekh A . Store-operated CRAC channels: function in health and disease. Nat Rev Drug Discov. 2010; 9(5):399-410. DOI: 10.1038/nrd3136. View

4.
Li C, Yang Z, Li Z, Ma Y, Zhang L, Zheng C . Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways. J Bone Miner Res. 2010; 26(3):644-56. DOI: 10.1002/jbmr.242. View

5.
Huynh H, Wan Y . mTORC1 impedes osteoclast differentiation via calcineurin and NFATc1. Commun Biol. 2018; 1:29. PMC: 6123628. DOI: 10.1038/s42003-018-0028-4. View